Cambridge Epigenetix (also known as CEGX) is a bioscience company that uses epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw using the 5-hydroxymethylcytosine (5hmC) epigenetic modification. The company is utilizing technologies, often based on fundamental chemistry, to detect the epigenetic biomarkers that will be most useful in clinical settings.